Ryan Ziemiecki

917 total citations
28 papers, 621 citations indexed

About

Ryan Ziemiecki is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ryan Ziemiecki has authored 28 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ryan Ziemiecki's work include Lymphoma Diagnosis and Treatment (5 papers), Diabetes Treatment and Management (4 papers) and Eosinophilic Esophagitis (3 papers). Ryan Ziemiecki is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Diabetes Treatment and Management (4 papers) and Eosinophilic Esophagitis (3 papers). Ryan Ziemiecki collaborates with scholars based in United States, Spain and Sweden. Ryan Ziemiecki's co-authors include Xiaolei Zhou, Dat Nguyen, L. Zografos, Dana DiBenedetti, Alicia Gilsenan, William R. Lincourt, Héctor Ortega, Richard H. Stanford, Michelle Byrtek and Jonathan W. Friedberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Ryan Ziemiecki

25 papers receiving 596 citations

Peers

Ryan Ziemiecki
Ryan Ziemiecki
Citations per year, relative to Ryan Ziemiecki Ryan Ziemiecki (= 1×) peers Luciano de Melo Pompei

Countries citing papers authored by Ryan Ziemiecki

Since Specialization
Citations

This map shows the geographic impact of Ryan Ziemiecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Ziemiecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Ziemiecki more than expected).

Fields of papers citing papers by Ryan Ziemiecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Ziemiecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Ziemiecki. The network helps show where Ryan Ziemiecki may publish in the future.

Co-authorship network of co-authors of Ryan Ziemiecki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Ziemiecki. A scholar is included among the top collaborators of Ryan Ziemiecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Ziemiecki. Ryan Ziemiecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kövesdy, Csaba P., Natalie Ebert, David Vizcaya, et al.. (2025). Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform. ˜The œNephron journals/Nephron journals. 149(7). 371–383.
2.
Rousculp, Matthew D., Kelly Hollis, Ryan Ziemiecki, et al.. (2024). Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines. Vaccines. 12(7). 802–802. 2 indexed citations
3.
Rousculp, Matthew D., Kelly Hollis, Ryan Ziemiecki, et al.. (2024). Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study. Vaccines. 12(1). 83–83. 4 indexed citations
4.
Gold, Benjamin D., Carolyn Sweeney, Ryan Ziemiecki, et al.. (2024). Satisfaction With and Adherence to Off-Label Corticosteroids in Adolescents and Adults With Eosinophilic Esophagitis. Journal of Clinical Gastroenterology. 59(2). 138–146. 1 indexed citations
5.
Osborne, Richard H., Lauren Nelson, Sheri Fehnel, et al.. (2023). Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores. Journal of Patient-Reported Outcomes. 7(1). 51–51. 5 indexed citations
6.
Danysh, Heather E., Catherine B. Johannes, Daniel C. Beachler, et al.. (2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Safety. 46(2). 175–193. 2 indexed citations
7.
Johannes, Catherine B., Daniel C. Beachler, J. Bradley Layton, et al.. (2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Safety. 46(2). 157–174. 5 indexed citations
9.
Johannes, Catherine B., J. Bradley Layton, Daniel C. Beachler, et al.. (2021). 805-P: Risk of Severe Complications of Urinary Tract Infection in Real-World Use of Dapagliflozin. Diabetes. 70(Supplement_1).
10.
Johannes, Catherine B., J. Bradley Layton, Daniel C. Beachler, et al.. (2021). 806-P: Risk of Acute Liver Injury in Real-World Use of Dapagliflozin. Diabetes. 70(Supplement_1). 1 indexed citations
11.
Fortuny, Joan, Alicia Gilsenan, Miguel Cainzos‐Achirica, et al.. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Safety. 42(10). 1167–1177. 3 indexed citations
12.
Gilsenan, Alicia, Joan Fortuny, Miguel Cainzos‐Achirica, et al.. (2019). Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. Drug Safety. 42(10). 1179–1190. 23 indexed citations
13.
Arana, Alejandro, Andrea V. Margulis, Lisa J. McQuay, et al.. (2018). Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(6). 628–637. 13 indexed citations
14.
Nastoupil, Loretta J., Rajni Sinha, Michelle Byrtek, et al.. (2016). Outcomes following watchful waiting for stage IIIV follicular lymphoma patients in the modern era. British Journal of Haematology. 172(5). 724–734. 38 indexed citations
15.
Nastoupil, Loretta J., Rajni Sinha, Michelle Byrtek, et al.. (2014). Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States. Leukemia & lymphoma. 56(5). 1295–1302. 17 indexed citations
16.
Yardley, Denise A., Gabriel N. Hortobágyi, Fabienne Lebrun, et al.. (2013). Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2.. Journal of Clinical Oncology. 31(26_suppl). 155–155. 2 indexed citations
17.
Sinha, Rajni, Michelle Byrtek, Ajay K. Nooka, et al.. (2011). Examining the Outcomes of Watchful Waiting (WW) Among US Patients with Advanced Stage Follicular Lymphoma (FL). Blood. 118(21). 775–775. 6 indexed citations
18.
Liu, Andrew H., Alicia Gilsenan, Richard H. Stanford, et al.. (2010). Status of Asthma Control in Pediatric Primary Care: Results from the Pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS). The Journal of Pediatrics. 157(2). 276–281.e3. 56 indexed citations
19.
Lock, Eric F., Ryan Ziemiecki, J. S. Marron, & Dirk P. Dittmer. (2010). Efficiency clustering for low-density microarrays and its application to QPCR. BMC Bioinformatics. 11(1). 386–386. 7 indexed citations
20.
Stanford, Richard H., Alicia Gilsenan, Ryan Ziemiecki, et al.. (2010). Predictors of Uncontrolled Asthma in Adult and Pediatric Patients: Analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). Journal of Asthma. 47(3). 257–262. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026